Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Make the Diagnosis: Can You Explain Her Rash and Conjunctival Injection?

2.

Should the UK introduce targeted prostate cancer screening? The case for and against

3.

Real-World EV Plus Pembro Success Seen in Urothelial Cancer

4.

In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.

5.

Investigating the Relationship Between GERD and Anxiety/Depression.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot